Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions: the Prostate CancerTreatment, your experience (PiCTure) study
Drummond FJ, Kinnear H, Donnelly C, O'Leary E, O'Brien K, Burns RM, Gavin A, Sharp L.
BMJ Open, 2015 April 17; 5(4): e006851
Richéal was appointed senior researcher in October 2014 after previously holding a joint position at HERC and the Surgical Intervention Trials Unit (SITU), where Richéal undertook health economic evaluations alongside a range of surgical trials including the UK TAVI trial. Previous to this, Richéal was based at NUI Galway, undertaking a MSc in Health Economics in 2009-2010 and following on to commence a DPhil (PhD) in 2011 funded by the Health Research Board; the research project afforded the opportunity to regularly visit HERC from October 2012 working on the modelling aspects of her DPhil with Dr. Jane Wolstenholme and Dr. José Leal. While at NUI Galway, Richéal also secured several internal grants to undertake various projects relating to quality of life and mental health concerns of the student population as well as teaching microeconomics, econometrics and quantitative research methods at both the undergraduate and postgraduate level for three years.
In her new role, Richéal will continue to provide health economic support alongside a range of RCTs as well as involvement in burden of cost studies. Having a keen interest in mental health, PROMs and inequality in health outcomes, Richéal will also follow on from previous work in the research areas of Prostate Cancer, Inflammatory Bowel Disease and general well-being.
The burden of healthcare costs associated with prostate cancer in Ireland
Burns RM. et al, (2017), Global and regional health technology assessment, 4, 0 - 0
A systematic review of analytical methods applied for discarded organs in kidney and liver transplantation research.
Richéal Burns et al, (2016), PROSPERO 2016:CRD42016049183
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370
Economic burden of non-malignant blood disorders across Europe: a population-based cost study
Luengo-Fernandez, R et al, (2016), The Lancet Haematology